DK3793534T3 - Oral tablet til levering af aktive ingredienser til mavetarmkanalen - Google Patents
Oral tablet til levering af aktive ingredienser til mavetarmkanalen Download PDFInfo
- Publication number
- DK3793534T3 DK3793534T3 DK19729181.8T DK19729181T DK3793534T3 DK 3793534 T3 DK3793534 T3 DK 3793534T3 DK 19729181 T DK19729181 T DK 19729181T DK 3793534 T3 DK3793534 T3 DK 3793534T3
- Authority
- DK
- Denmark
- Prior art keywords
- delivery
- active ingredients
- gastrointestinal tract
- oral tablet
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/982,593 US20190350858A1 (en) | 2018-05-17 | 2018-05-17 | Oral tablet for delivery of active ingredients to the gastrointestinal tract |
| PCT/DK2019/050159 WO2019219149A1 (en) | 2018-05-17 | 2019-05-15 | An oral tablet for delivery of active ingredients to the gastrointestinal tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3793534T3 true DK3793534T3 (da) | 2023-05-01 |
Family
ID=66793737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19729181.8T DK3793534T3 (da) | 2018-05-17 | 2019-05-15 | Oral tablet til levering af aktive ingredienser til mavetarmkanalen |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20190350858A1 (da) |
| EP (1) | EP3793534B1 (da) |
| CN (1) | CN112218624A (da) |
| CA (1) | CA3098086C (da) |
| DK (1) | DK3793534T3 (da) |
| ES (1) | ES2943835T3 (da) |
| PL (1) | PL3793534T3 (da) |
| WO (1) | WO2019219149A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11096894B2 (en) | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Oral tablet for induced saliva generation |
| CA3174693A1 (en) * | 2020-05-08 | 2021-11-11 | Fertin Pharma A/S | Flowpack for oral delivery of active ingredients |
| CN112220756B (zh) * | 2020-10-16 | 2023-06-13 | 重庆市义力医药科技有限公司 | 一种尼古丁颗粒组合物及其制备方法 |
| WO2022130040A1 (en) * | 2020-12-19 | 2022-06-23 | Cellix Bio Private Limited | A pharmaceutical composition comprising fexofenadine, famotidine and melatonin |
| WO2022157563A1 (en) * | 2021-01-23 | 2022-07-28 | Cellix Bio Private Limited | A pharmaceutical composition comprising lidocaine and melatonin |
| WO2023187664A1 (en) * | 2022-03-30 | 2023-10-05 | Avaca Pharma Private Limited | A pharmaceutical composition for the treatment of immune system mediated diseases |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1080024A (en) | 1975-12-24 | 1980-06-24 | Leonard Spooner | Confection containing xylitol |
| US4627977A (en) | 1985-09-13 | 1986-12-09 | Colgate-Palmolive Company | Anticalculus oral composition |
| US4820506A (en) | 1987-05-01 | 1989-04-11 | Research Foundation, State University Of New York | Salivary stimulant |
| US4997654A (en) * | 1989-08-14 | 1991-03-05 | Warner-Lambert Company | Method for increasing salivation for xerostomia patients |
| GB9100009D0 (en) | 1991-01-02 | 1991-02-20 | Cerestar Holding Bv | Erythritol compositions |
| US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
| TW469135B (en) | 1995-10-03 | 2001-12-21 | Chugai Pharmaceutical Co Ltd | Chewable tablet |
| RU2189227C2 (ru) | 1996-07-12 | 2002-09-20 | Дайити Фармасьютикал Ко., Лтд. | Быстро распадающиеся прессованные в формах материалы и способ их получения |
| US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| GB9716432D0 (en) | 1997-08-05 | 1997-10-08 | Cerestar Holding Bv | Tableting of erythritol |
| US5922346A (en) * | 1997-12-01 | 1999-07-13 | Thione International, Inc. | Antioxidant preparation |
| US5874068A (en) | 1997-12-08 | 1999-02-23 | Warner-Lambert Company | Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts |
| WO1999032092A1 (en) | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Process for manufacturing bite-dispersion tablets |
| AU1031500A (en) | 1998-11-03 | 2000-05-22 | Dandy A/S | Sucrose fatty acid esters for use as increased release of active ingredients |
| FR2785538B1 (fr) | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
| AR032556A1 (es) * | 2001-02-08 | 2003-11-12 | Pharmacia Corp | Medicamento de accion inmediata para el tratamiento de la disfuncion sexual |
| JPWO2002069934A1 (ja) | 2001-03-06 | 2004-07-02 | 協和醗酵工業株式会社 | 口腔内速崩壊性製剤 |
| SE0102197D0 (sv) | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
| JP2005526095A (ja) | 2002-03-20 | 2005-09-02 | エラン ファーマ インターナショナル，リミティド | 脆砕性の低い急速溶解投与剤型 |
| JP2006513704A (ja) | 2003-02-04 | 2006-04-27 | ガムリンク エー／エス | 圧縮チューインガムタブレット |
| US7223072B2 (en) | 2004-01-27 | 2007-05-29 | Honeywell International, Inc. | Gas turbine engine including airfoils having an improved airfoil film cooling configuration and method therefor |
| WO2006063189A2 (en) | 2004-12-10 | 2006-06-15 | Novartis Ag | Multi-layered chewing gum tablet with quick disintegration layer |
| US8435542B2 (en) | 2005-03-03 | 2013-05-07 | Takasago International Corp. (Usa) | Synergistic salivation agents |
| ATE462416T1 (de) * | 2006-08-04 | 2010-04-15 | Ethypharm Sa | Mehrschichtige im mund zerfallende tablette |
| WO2009007768A1 (en) | 2007-07-06 | 2009-01-15 | Gumlink A/S | Compressed tablet comprising polyol |
| EP2264042B1 (en) | 2007-07-27 | 2012-07-18 | Cargill, Incorporated | Micronization of polyols |
| WO2009080023A1 (en) | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising peptide |
| PT2334202E (pt) | 2008-09-04 | 2012-02-28 | Cargill Inc | Fabrico de comprimidos de eritritol |
| ES2588429T3 (es) | 2009-03-09 | 2016-11-02 | Spi Pharma, Inc. | Excipientes y sistemas de excipientes de compresión directa altamente compactables y durables |
| US9591852B2 (en) | 2009-11-23 | 2017-03-14 | Mcneil-Ppc, Inc. | Biofilm disruptive compositions |
| US8658139B1 (en) | 2010-02-27 | 2014-02-25 | Squigle, Inc. | Prevention and treatment of oral diseases |
| WO2012085043A2 (en) | 2010-12-22 | 2012-06-28 | Basf Se | Rapidly disintegrating, solid coated dosage form |
| WO2013091631A1 (en) * | 2011-12-22 | 2013-06-27 | Fertin Pharma A/S | Method of releasing nicotine from chewing gum |
| JP6040218B2 (ja) | 2012-02-23 | 2016-12-07 | フロイント産業株式会社 | 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠 |
| WO2013171164A1 (en) * | 2012-05-14 | 2013-11-21 | EJP Pharmaceutical ApS | Compositions and formulations for the treatment of halitosis |
| AU2014266070A1 (en) | 2013-05-17 | 2015-12-10 | Alequident Limited | Oral healthcare product |
| US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
| WO2016061486A1 (en) | 2014-10-16 | 2016-04-21 | Cargill, Incorporated | Process for preparing a directly compressible erythritol & uses thereof |
| WO2016077464A1 (en) | 2014-11-11 | 2016-05-19 | Johnson & Johnson Consumer Inc. | Amino acid derivatives and their uses |
| JP6908717B2 (ja) * | 2016-11-18 | 2021-07-28 | フェルティン ファルマ アー／エス | 経口送達ビヒクル |
| US10632076B2 (en) | 2016-11-18 | 2020-04-28 | Fertin Pharma A/S | Tablet comprising separate binder and erythritol |
| US11351103B2 (en) | 2016-11-18 | 2022-06-07 | Johnson & Johnson Consumer Inc. | Method of providing oral care benefits |
| US10543205B2 (en) | 2016-11-18 | 2020-01-28 | Fertin Pharma A/S | Oral delivery vehicle containing nicotine |
| JP6840849B2 (ja) | 2016-11-18 | 2021-03-10 | フェルティン ファルマ アー／エス | 別個の結合剤及びエリスリトールを含む錠剤 |
-
2018
- 2018-05-17 US US15/982,593 patent/US20190350858A1/en not_active Abandoned
-
2019
- 2019-05-15 DK DK19729181.8T patent/DK3793534T3/da active
- 2019-05-15 WO PCT/DK2019/050159 patent/WO2019219149A1/en active Application Filing
- 2019-05-15 PL PL19729181.8T patent/PL3793534T3/pl unknown
- 2019-05-15 CA CA3098086A patent/CA3098086C/en active Active
- 2019-05-15 EP EP19729181.8A patent/EP3793534B1/en active Active
- 2019-05-15 ES ES19729181T patent/ES2943835T3/es active Active
- 2019-05-15 CN CN201980032442.5A patent/CN112218624A/zh active Pending
-
2021
- 2021-06-10 US US17/344,373 patent/US11260030B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN112218624A (zh) | 2021-01-12 |
| US20210299052A1 (en) | 2021-09-30 |
| CA3098086A1 (en) | 2019-11-21 |
| WO2019219149A1 (en) | 2019-11-21 |
| EP3793534B1 (en) | 2023-04-05 |
| CA3098086C (en) | 2023-10-17 |
| PL3793534T3 (pl) | 2023-06-05 |
| EP3793534A1 (en) | 2021-03-24 |
| ES2943835T3 (es) | 2023-06-16 |
| US11260030B2 (en) | 2022-03-01 |
| US20190350858A1 (en) | 2019-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3793534T3 (da) | Oral tablet til levering af aktive ingredienser til mavetarmkanalen | |
| DK3506884T3 (da) | Sammensætninger til indgivelse af medicin og anvendelser af disse | |
| DK3383363T3 (da) | Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande | |
| DK3068392T5 (da) | Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme | |
| MA52257A (fr) | Compositions pharmaceutiques comprenant blautia et leur administration orale | |
| DK3727555T3 (da) | Oral delivery of active drug substances | |
| BR112016021012A2 (pt) | composições farmacêuticas de compostos terapeuticamente ativos. | |
| DK3634468T3 (da) | Fast sammensætning til oral indgivelse | |
| DK3785733T3 (da) | Farmaceutisk sammensætning til behandling af autisme | |
| DK3937902T3 (da) | Farmaceutisk doseringsform til påføring på slimhinder og fremgangsmåder til fremstilling af denne | |
| DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
| DK3491993T3 (da) | Kobling til endoskopisk kamera. | |
| DK3551181T3 (da) | Behandling omfattende oral eller gastrisk indgivelse af edaravone | |
| FR3022462B1 (fr) | Composition orale d'anticorps anti-tnfalpha | |
| DK2956149T3 (da) | Farmaceutiske sammensætninger til behandling af helicobacter pylori | |
| DK3762009T3 (da) | Toxin-afledte indgivelseskonstrukter til oral indgivelse | |
| EP3784214A4 (en) | LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | |
| HK1248544A1 (zh) | 穩定的口服給藥用藥物組合物 | |
| DK3735228T3 (da) | Programmerbar farmaceutiske sammensætninger til krono-lægemiddelfrigivelse | |
| MA40781A (fr) | Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| DK2886108T4 (da) | Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus | |
| EP3346996A4 (en) | ORAL PHARMACEUTICAL PHARMACEUTICAL FORM OF BUDESONID | |
| DK3886813T3 (da) | Farmaceutiske formuleringer af cyclosporinanaloger | |
| DK3400017T3 (da) | Kontinuerlig kompleksering af aktive farmaceutiske ingredienser |